F11R and ovarian cancer: Kakogiannos et al. (14) reported that, compared to healthy controls, ovarian cancer patients exhibit the downregulation of junctional adhesion molecule-A (JAM-A) and the tight junction protein claudin-5 in their blood vessels, which weakens endothelial tight junctions and increases vascular permeability.